Company profile: Hemotune
1.1 - Company Overview
Company description
- Provider of a therapeutic blood purification platform and products: HemoSystem using magnetic beads to selectively remove large biomolecules for conditions like sepsis; HemoBeads with ultra-magnetic cores and affinity binders; HemoDevice, a reusable extracorporeal device; HemoDisposable sterile single-use tubing; and reSEPT Therapy to restore immune balance in septic shock.
Products and services
- HemoBeads: Non-toxic magnetic beads with an ultra-magnetic core and affinity binders engineered to target and remove specific compounds from blood within the HemoSystem
- HemoSystem: Custom-engineered blood purification platform that uses magnetic beads to selectively remove large biomolecules from the bloodstream, aimed at treating conditions like sepsis
- ReSEPT Therapy: Multi-target precision-medicine blood purification treatment aimed at restoring immune balance in septic shock patients during treatment of health ailments
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hemotune
Outset Medical
HQ: United States
Website
- Description: Provider of dialysis technology, including the Tablo Hemodialysis System for treating acute and chronic renal failure in hospitals and at home, featuring integrated water purification, touchscreen interface, and multiple dialysis modalities; TabloHub for two-way data transmission and remote patient monitoring; EMR Connect for EMR integration and automated documentation; and TabloCart for device transportation within clinical settings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Outset Medical company profile →
Theradial
HQ: France
Website
- Description: Provider of medical devices in France serving health actors in dialysis-nephrology, gastroenterology and onco-hematology. Offers Renoral nutritional supplement for hemodialysis patients; Hemadialyse and MEDWARE software for patient data/records; Théradata CNIL-authorized nephrology-dialysis data repository; InBody S10 and InBody BWA 2.0 bioimpedance analyzers, and partners with the medical and scientific community via clinical studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Theradial company profile →
ZyVersa Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics for inflammatory and renal diseases, including IC 100, a monoclonal antibody targeting ASC in inflammasomes to inhibit the initiation and perpetuation of inflammatory diseases, and VAR 200, a cholesterol efflux mediator that removes excess cholesterol from the kidney's filtration system to reduce proteinuria and preserve kidney function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZyVersa Therapeutics company profile →
Cadrenal Therapeutics
HQ: United States
Website
- Description: Provider of Tecarfarin, a late-stage novel oral anticoagulant targeting a different metabolic pathway than warfarin for patients with end-stage kidney disease (ESKD) and atrial fibrillation (AFib). Under development for anticoagulation needs of left ventricular assist device (LVAD) patients and those with Antiphospholipid Syndrome (APS), aiming for safer alternatives to warfarin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cadrenal Therapeutics company profile →
Physidia
HQ: France
Website
- Description: Provider of nephrology and home dialysis medical equipment, tools and training, including the S3 Monitor for daily home hemodialysis, SeCoHD therapy, home delivery of disposables, remote supervision transmitting session data to dialysis centers, and a technical hotline.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Physidia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hemotune
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hemotune
2.2 - Growth funds investing in similar companies to Hemotune
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hemotune
4.2 - Public trading comparable groups for Hemotune
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →